InsidersTradesSigma
Track the WuXi Biologics (Cayman) Inc. share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, WuXi Biologics (Cayman) Inc. has logged 14 reports. Market capitalisation: €204.4bn. The latest transaction was reported on 9 September 2026 (Other). Among the most active insiders: Chen Zhisheng. The full history is free.
14
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate WuXi Biologics (Cayman) Inc. Buy (bullish), based on 24 analysts. Average price target: HK$56.15.
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,050 of 29,063 companies
56.3
score / 100
Value37
Quality75
FCF yld1.3%
Earn yld2.4%
EV/EBITDA23.5x
ROE11%
Gross mgn46%
Net mgn23%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
Declarations14 total
2,400,000 shares@ HK$2.6367ShareXHKGHKEX:DA20260908E00492
1,500,000 shares@ HK$2.63670.0019% mcap100.0% of flowShareXHKGHKEX:DA20260907E00497
104,495 sharesShareXHKGHKEX:DA20260827E00572
15,117 sharesShareXHKGHKEX:DA20260827E00575
378,080 sharesShareXHKGHKEX:DA20260622E00526
264,866 sharesShareXHKGHKEX:DA20260615E00437
29,677 sharesShareXHKGHKEX:DA20260615E00438
148,127 sharesShareXHKGHKEX:DA20260401E00525
16,724 sharesShareXHKGHKEX:DA20260401E00527
54,838 sharesShareXHKGHKEX:DA20260330E00500
1,442,769 sharesShareXHKGHKEX:DA20260330E00499
543,819 sharesShareXHKGHKEX:DA20260330E00501
1,734 sharesShareXHKGHKEX:DA20260327E00406
6,713 sharesShareXHKGHKEX:DA20260326E00431
14 of 14 declarations
Acerca de WuXi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc. es una empresa especializada en servicios biofarmacéuticos, que ofrece soluciones de desarrollo y fabricación de productos biológicos. Cotiza en la Bolsa de Hong Kong bajo el símbolo XHKG.